News
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
Research leaders from OpenAI, Anthropic, and Google DeepMind are urging tech companies and research groups to monitor AI's ...
While ChatGPT emerged as the front-runner in this study, the authors caution against premature clinical adoption of any ...
Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...
Monitoring AI's train of thought is critical for improving AI safety and catching deception. But we're at risk of losing this ...
The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...
Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.
5d
Tech Xplore on MSNNew research reveals AI has a confidence problemLarge language models (LLMs) sometimes lose confidence when answering questions and abandon correct answers, according to a ...
(Reuters) -Google has hired Windsurf CEO Varun Mohan, co-founder Douglas Chen, and select members of the coding tool's ...
The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results